4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cutting Edge: Innate Lymphoid Cells Suppress Homeostatic T Cell Expansion in Neonatal Mice.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In adult mice, lymphopenia-induced proliferation (LIP) leads to T cell activation, memory differentiation, tissue destruction, and a loss of TCR diversity. Neonatal mice are lymphopenic within the first week of life. This enables some recent thymic emigrants to undergo LIP and convert into long-lived memory T cells. Surprisingly, however, most neonatal T cells do not undergo LIP. We therefore asked whether neonate-specific mechanisms prevent lymphopenia-driven T cell activation. In this study, we show that IL-7R-dependent innate lymphoid cells (ILCs) block LIP of CD8(+) T cells in neonatal but not adult mice. Importantly, CD8(+) T cell responses against a foreign Ag are not inhibited by neonatal ILCs. This ILC-based inhibition of LIP ensures the generation of a diverse naive T cell pool in lymphopenic neonates that is mandatory for the maintenance of T cell homeostasis and immunological self-tolerance later in life.

          Related collections

          Author and article information

          Journal
          J. Immunol.
          Journal of immunology (Baltimore, Md. : 1950)
          The American Association of Immunologists
          1550-6606
          0022-1767
          May 01 2016
          : 196
          : 9
          Affiliations
          [1 ] Institute of Molecular and Clinical Immunology, Medical Faculty, Otto von Guericke University, 39120 Magdeburg, Germany;
          [2 ] Division of Developmental Immunology, Department of Biomedicine, University of Basel, CH-4058 Basel, Switzerland; and.
          [3 ] Department of Molecular Immunology, German Cancer Research Center, 69120 Heidelberg, Germany.
          [4 ] Institute of Molecular and Clinical Immunology, Medical Faculty, Otto von Guericke University, 39120 Magdeburg, Germany; thomas.schueler@med.ovgu.de.
          Article
          jimmunol.1501643
          10.4049/jimmunol.1501643
          26983785
          6ab18974-3a64-4691-afa4-ffc3d2b827ad
          History

          Comments

          Comment on this article